Entero Therapeutics Inc (ENTO)
1.76
-0.01
(-0.65%)
USD |
NASDAQ |
Jun 25, 16:00
1.73
-0.03
(-1.70%)
After-Hours: 20:00
Entero Therapeutics Cash from Financing (Quarterly): 3.379M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 3.379M |
| December 31, 2023 | 4.359M |
| September 30, 2023 | 5.388M |
| June 30, 2023 | 1.933M |
| March 31, 2023 | 3.547M |
| December 31, 2022 | 5.524M |
| September 30, 2022 | 4.772M |
| June 30, 2022 | 0.0764M |
| March 31, 2022 | 5.367M |
| December 31, 2021 | 17.07M |
| September 30, 2021 | 14.86M |
| June 30, 2021 | 1.782M |
| March 31, 2021 | 11.05M |
| December 31, 2020 | 0.5524M |
| September 30, 2020 | 13.06M |
| June 30, 2020 | 0.6773M |
| March 31, 2020 | 2.756M |
| December 31, 2019 | 1.846M |
| September 30, 2019 | 4.403M |
| Date | Value |
|---|---|
| June 30, 2019 | 4.928M |
| March 31, 2019 | 1.967M |
| December 31, 2018 | 0.255M |
| September 30, 2018 | -0.3132M |
| June 30, 2018 | 9.525M |
| March 31, 2018 | 2.246M |
| December 31, 2017 | 0.1592M |
| September 30, 2017 | 0.338M |
| June 30, 2017 | 5.593M |
| March 31, 2017 | -0.0773M |
| December 31, 2016 | 3.652M |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 1.869M |
| March 31, 2016 | 0.225M |
| December 31, 2015 | -0.3082M |
| September 30, 2015 | 3.185M |
| June 30, 2015 | 0.644M |
| March 31, 2015 | 1.16M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
0.0764M
Minimum
Jun 2022
17.07M
Maximum
Dec 2021
5.367M
Average
4.381M
Median
Cash from Financing (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.597M |
| Palatin Technologies Inc | 9.136M |
| iBio Inc | 5.025M |
| Theriva Biologics Inc | 0.00 |
| Oragenics Inc | 1.653M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.747M |
| Cash from Investing (Quarterly) | 0.0882M |
| Free Cash Flow | -13.28M |
| Free Cash Flow Per Share (Quarterly) | -0.2582 |
| Free Cash Flow Yield | -178.2% |